PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer

Norman Fultang(University of the Sciences), Neha Bhagwat
Frontiers in Oncology
February 2, 2024
Cited by 5


Related Papers